JPRN-C000000093已完成3 期
Comparative study of neoadjuvant MVAC chemotharapy plus radical systectomy with radical cystectomy alone for imparovent of survival of patients with invasive bladder cancer (T2-4aN0M0)(JCOG0209, BC MVAC Phase III) - Comparative study of neoadjuvant MVAC chemotharapy plus radical systectomy with radical cystectomy alone for imparovent of survival of patients with invasive bladder cancer (T2-4aN0M0)(JCOG0209, BC MVAC Phase III)
Japan Clinical Oncology Group(JCOG)0 个研究点目标入组 360 人开始时间: 2005年8月30日最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 360
研究概览
简要总结
See the datails via "URL releasing results" above. Also the details can be seen in the JCOG website: http://www.jcog.jp/en/trials/index.html
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •patients who meet one of criteria below are excluded. 1) active cancer simultaneously occurred in organs other than the urinary tract 2) women who are pregnant, possibly pregnant or lactating 3) patients with psychological disorders or symptoms 4) patients who has recived systemic steroid treatment 5) serious comorbiditirs IHD or arrythemia that should be reated history of myocarddial infarction occured within 6 months liver cirrhosis interstitial pneumonitis, pulmonary fibrosis, or repiratory diseases needing O2 inhalation uncontrolable diabetes 6) patients inapprppriate for the study entry determined by a doctor
研究者
相似试验
已完成
2 期
Feasibility study of neoadjuvant chemotherapy followed by interval cytoreductive surgery for stage III/IV ovarian, tubal and peritoneal cancers.(JCOG0206, OVCA-NAC-P2)stage III/IV ovarian, tubal and peritoneal carcinomasJPRN-C000000005Japan Clinical Oncology Group(JCOG)56
已完成
3 期
Phase III trial of neoadjuvant chemotherapy followed by surgery versus surgery alone for bulky stage I/II cervical cancer: Japan Clinical Oncology Group trial (JCOG0102)Patients with cervical cancerJPRN-C000000194Japan Clinical Oncology Group(JCOG)200
Unknown
3 期
Comparison the Effects of Different Neoadjuvant Chemotherapy Regimen on Acute Toxicity, Tumor Response, and Survival in Patients With Advanced Nasopharyngeal CarcinomaNasopharyngeal CarcinomaNCT02500940Taichung Veterans General Hospital54
已完成
3 期
Phase III study of VCAP-AMP-VECP vs. biweekly CHOP in aggressive adult T-cell leukemia-lymphoma (ATLL): Japan Clinical Oncology Group Study, JCOG9801.adult T-cell leukemia / lymphomaJPRN-C000000066Japan Clinical Oncology Group(JCOG)130
已完成
2 期
A Randomized PhaseII/III Study of Concurrent Chemoradiotherapy with Low Dose Cisplatin plus 5-FU versus Concurrent Chemoraiotherapy with Standard Dose Cisplatin plus 5-FU for Locally Advanced Unresetable Esophageal Cancer in the Thorax.(JCOG0303)ocally advanced unresectable esophageal cancer in the thoraxJPRN-UMIN000000861Japan Clinical Oncology Group(JCOG)364